Nan Fung Group Holdings’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Hold
19,253
2.74% 10
2026
Q1
$1.87M Hold
19,253
1.54% 16
2025
Q4
$1.53M Hold
19,253
1.37% 17
2025
Q3
$899K Hold
19,253
1.51% 17
2025
Q2
$708K Hold
19,253
1.12% 14
2025
Q1
$681K Hold
19,253
0.56% 26
2024
Q4
$842K Buy
19,253
+11,953
+164% +$603K 0.72% 27
2024
Q3
$331K Hold
7,300
0.29% 31
2024
Q2
$283K Hold
7,300
0.3% 33
2024
Q1
$235K Buy
+7,300
New +$216K 0.22% 38

Other funds holding RVMD

Nan Fung Group Holdings's RVMD Position: Q2 2026 in Review

Nan Fung Group Holdings held its Revolution Medicines (RVMD) position steady in Q2 2026 at 19,253 shares worth $3.61M. The position accounts for 2.74% of the portfolio, ranked #10.

Nan Fung Group Holdings first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Nan Fung Group Holdings held 19,253 shares of Revolution Medicines worth $3.61M as of Q2 2026.
  • Nan Fung Group Holdings left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 2.74% of Nan Fung Group Holdings's portfolio in Q2 2026, its #10 holding.
  • Nan Fung Group Holdings first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Nan Fung Group Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.